Paroma Arefin | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Paroma Arefin
Affiliation University of Houston
Country United States
Scopus ID 57041256700
Documents 15
Citations 67
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0002-5968-1002

Paroma Arefin

Institution: University of Houston, United States

Paroma Arefin is a researcher whose scholarly work spans pharmaceutical sciences, proton exchange membrane fuel cells, hydrogen energy technologies, biomaterials, and public health research. Her interdisciplinary publications demonstrate contributions to pharmaceutical formulation, sustainable energy systems, healthcare technologies, and consumer health awareness. Through peer-reviewed research, she has participated in studies addressing fuel cell durability, drug delivery systems, mobility assistance technologies, and healthcare education, reflecting an interdisciplinary approach that bridges engineering and pharmaceutical sciences.[1]

Abstract

This article summarizes the academic profile and research achievements of Paroma Arefin in recognition of the Women Researcher Award. Her publications primarily address proton exchange membrane fuel cells, hydrogen-powered transportation, pharmaceutical formulation, biomaterials, and healthcare studies. These contributions demonstrate interdisciplinary scholarship that combines pharmaceutical sciences with emerging sustainable energy technologies and applied healthcare research. Her publication record, citation profile, and collaborative research activities illustrate continued participation in internationally visible scientific literature.[1][2]

Keywords

Women Researcher Award, Paroma Arefin, Pharmaceutical Science, Proton Exchange Membrane Fuel Cell, Hydrogen Energy, Drug Delivery, Biomaterials, Fuel Cell Durability, Healthcare Research, University of Houston.

Introduction

Interdisciplinary scientific research increasingly contributes to addressing global healthcare and energy challenges. Paroma Arefin’s scholarly work reflects this trend through publications involving pharmaceutical formulations, hydrogen fuel cell technology, mobility assistance devices, and public health awareness. Her research integrates engineering concepts with pharmaceutical sciences to explore practical solutions that may contribute to healthcare innovation and sustainable energy development.[2]

Research Profile

  • Affiliation: University of Houston.
  • Research specialization includes Pharmacology, Toxicology and Pharmaceutical Science.
  • Scopus Author ID: 57041256700.
  • Research output includes interdisciplinary studies in pharmaceutical sciences, hydrogen fuel cells and healthcare.
  • Publication metrics include 15 indexed documents, 67 citations and an h-index of 6.

Research Contributions

Paroma Arefin has co-authored review articles examining durability factors affecting proton exchange membrane fuel cells, including the influence of operating temperature and membrane degradation mechanisms. These studies provide comprehensive overviews of hydrogen fuel cell technologies and summarize engineering challenges affecting long-term performance.[3]

Her pharmaceutical research includes formulation and characterization of controlled-release microspheres containing Fexofenadine hydrochloride, contributing to studies on drug delivery systems and controlled pharmaceutical release technologies.[4]

Additional publications address consumer awareness regarding food adulteration, mobility assistive devices for elderly populations, and hydrogen-powered transportation systems, demonstrating broad interdisciplinary engagement across engineering and health sciences.[5]

Publications

  • Effect of temperature on the performance factors and durability of proton exchange membrane of hydrogen fuel cell: A narrative review (2020).
  • Proton exchange membrane fuel cell durability factors, challenges, and future perspectives: A detailed review (2021).
  • Study on awareness about food adulteration and consumer rights among consumers in Dhaka, Bangladesh (2020).
  • Adoption of hydrogen fuel cell vehicles and its prospects for the future: A review (2022).
  • Design, characterization and in vitro evaluation of HPMC K100 M CR loaded Fexofenadine HCl microspheres (2016).
  • A comparison of mobility assistive devices for elderly and patients with lower limb injury: Narrative Review.

Research Impact

Citation indicators demonstrate measurable academic visibility within pharmaceutical science and hydrogen energy research. Review articles concerning proton exchange membrane fuel cells have contributed to knowledge synthesis in sustainable energy technologies, while pharmaceutical formulation studies support advances in controlled drug delivery. Collectively, these works reflect interdisciplinary collaboration and continued scholarly engagement across multiple research domains.[1][3]

Award Suitability

Based on her documented publication record, interdisciplinary collaborations, citation profile, and research contributions spanning pharmaceutical sciences, hydrogen fuel cell technologies, healthcare applications, and public health, Paroma Arefin demonstrates characteristics consistent with recognition through the Women Researcher Award. Her research portfolio illustrates continued scholarly activity, international collaboration, and contributions to scientific literature relevant to sustainable technologies and pharmaceutical innovation.[1]

Conclusion

Paroma Arefin’s academic record demonstrates interdisciplinary scholarship across pharmaceutical science, sustainable energy technologies, healthcare engineering, and biomedical research. Her publications, citation metrics, and collaborative research activities collectively represent meaningful contributions to contemporary scientific literature. The combination of pharmaceutical innovation and engineering-focused sustainability research supports her recognition within international academic award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Paroma Arefin, Author ID 57041256700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57041256700
  2. Salam, M. A., Habib, M. S., Arefin, P., Ahmed, K., Uddin, S., Hossain, T., & Papri, N. (2020).
    Effect of Temperature on the Performance Factors and Durability of Proton Exchange Membrane of Hydrogen Fuel Cell: A Narrative Review.
    Material Science Research India, 17(2), 179–191.
    DOI: https://doi.org/10.13005/msri/170207
  3. Habib, M. S., Arefin, P., Salam, M. A., Ahmed, K., Uddin, M. S., Hossain, T., Papri, N., et al. (2021). Proton Exchange Membrane Fuel Cell (PEMFC) Durability Factors, Challenges, and Future Perspectives: A Detailed Review.
    Material Science Research India, 18(2), 217–234.
    DOI: https://doi.org/10.13005/msri/180209
  4. Arefin, P., Hasan, I., & Reza, M. S. (2016).
    Design, Characterization and In Vitro Evaluation of HPMC K100 M CR Loaded Fexofenadine HCl Microspheres.  SpringerPlus, 5, 691. DOI: https://doi.org/10.1186/s40064-016-2322-2
  5. Habib, M. S., & Arefin, P. (2022).
    Adoption of Hydrogen Fuel Cell Vehicles and Its Prospects for the Future (A Review).
    Oriental Journal of Chemistry, 38(3), 621–631. DOI: https://doi.org/10.13005/ojc/380311

Chenglei Fan | Medicine and Dentistry | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

Chenglei Fan
Affiliation School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences
Country China
ORCID ID 0000-0002-1129-0379
Documents 11
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Researcher: Chenglei Fan
Institution : School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, China

Chenglei Fan is affiliated with the School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, China. His scholarly work contributes to musculoskeletal anatomy, fascia research, rehabilitation science, connective tissue biology, imaging, and clinical anatomy. His peer-reviewed publications investigate the structural organization of fascia, ligaments, extracellular matrix composition, and age-related musculoskeletal changes using anatomical, histological, imaging, and clinical methodologies. These contributions demonstrate an interdisciplinary approach that supports evidence-based rehabilitation and orthopedic medicine.[1]

Abstract

The scientific contributions of Chenglei Fan emphasize the anatomical and biomechanical understanding of musculoskeletal tissues relevant to rehabilitation medicine. His publications integrate gross anatomy, histology, magnetic resonance imaging, ultrasound imaging, and extracellular matrix biology to improve knowledge of fascia, ligaments, tendons, and connective tissues. This body of work supports improved clinical diagnosis, rehabilitation planning, and evidence-based treatment strategies for musculoskeletal disorders.[2]

Keywords

Medicine, Rehabilitation Science, Clinical Anatomy, Fascia Research, Histology, MRI, Connective Tissue, Musculoskeletal System, Knee Joint, Extracellular Matrix, Orthopedics, Human Anatomy.

Introduction

Modern rehabilitation medicine increasingly depends upon detailed anatomical and imaging-based evidence to optimize diagnosis and therapeutic interventions. Chenglei Fan’s research addresses clinically important questions regarding fascia, ligament morphology, extracellular matrix remodeling, and connective tissue organization. His work contributes valuable anatomical evidence that supports both orthopedic surgery and rehabilitation practice while expanding understanding of tissue biomechanics.[3]

Research Profile

  • Affiliation: School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences.
  • Research discipline: Medicine and Dentistry.
  • Primary research areas include fascia biology, musculoskeletal anatomy, connective tissue morphology, rehabilitation science, and clinical imaging.
  • Research integrates anatomical dissection, histology, MRI, ultrasound imaging, and clinical observations.
  • Published research documents: 11.

Research Contributions

The published research portfolio demonstrates systematic investigation of connective tissue anatomy and pathology. Studies have clarified anatomical distinctions within the knee joint, characterized extracellular matrix alterations associated with aging, evaluated fascia lata changes in hip osteoarthritis, and reviewed fascial involvement in diabetic foot disorders. Additional work combines macroscopic anatomy, microscopy, and imaging technologies to improve structural understanding of fascial tissues relevant to rehabilitation medicine.[2][4]

Publications

  • Are Patellofemoral Ligaments and Retinacula Distinct Structures of the Knee Joint? An Anatomic, Histological and Magnetic Resonance Imaging Study (2022).
  • Age-Related Alterations of Hyaluronan and Collagen in Extracellular Matrix of the Muscle Spindles (2021).
  • Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study (2021).
  • Diabetic Foot: The Role of Fasciae, a Narrative Review (2021).
  • An Anatomical Comparison of the Fasciae of the Thigh: A Macroscopic, Microscopic and Ultrasound Imaging Study (2021).

Research Impact

The available publications demonstrate consistent contributions toward improving scientific understanding of musculoskeletal connective tissues and their clinical relevance. By integrating anatomical investigation with imaging and histological analyses, the research supports improved rehabilitation assessment, orthopedic procedures, and translational medical research. These multidisciplinary investigations contribute useful evidence for clinicians, anatomists, and rehabilitation specialists.[5]

Award Suitability

Based on the documented publication record, interdisciplinary research themes, and focus on clinically relevant anatomical investigations, Chenglei Fan demonstrates qualifications consistent with recognition in academic research. His work illustrates sustained contributions to rehabilitation science and medicine through evidence-based anatomical research, multidisciplinary methodologies, and publication in reputable peer-reviewed journals. These characteristics align with the objectives commonly associated with international academic research recognition programs.[1]

Conclusion

Chenglei Fan’s scholarly contributions strengthen the scientific understanding of fascia, ligaments, connective tissues, and musculoskeletal anatomy. Through rigorous anatomical, histological, and imaging-based investigations, the research advances rehabilitation medicine while supporting future developments in orthopedic science, clinical diagnosis, and patient-centered therapeutic strategies.

References

  1. ORCID. (n.d.). Chenglei Fan ORCID Record.
    https://orcid.org/0000-0002-1129-0379
  2. Fan, C. et al. (2022). Are Patellofemoral Ligaments and Retinacula Distinct Structures of the Knee Joint? An Anatomic, Histological and Magnetic Resonance Imaging Study.https://doi.org/10.3390/ijerph19031110
  3. Fan, C. et al. (2021). Age-Related Alterations of Hyaluronan and Collagen in Extracellular Matrix of the Muscle Spindles.
    https://doi.org/10.3390/jcm11010086
  4. Fan, C. et al. (2021). Fascia Lata Alterations in Hip Osteoarthritis.
    https://doi.org/10.3390/life11111136
  5. Fan, C. et al. (2021). Diabetic Foot: The Role of Fasciae.
    https://doi.org/10.3390/biology10080759

Promise Paul | Biochemistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Promise Paul
Affiliation Michael Okpara University of Agriculture, Umudike
Country Nigeria
Google Scholar ID o4j7GMIAAAAJ
Documents 6
Citations 24
h-index 1
Subject Area Biochemistry
Event International Academic Achievements & Awards
ORCID 0009-0002-7532-8409

Researcher: Promise Paul
Institution: Michael Okpara University of Agriculture, Umudike

Promise Paul is a researcher affiliated with Michael Okpara University of Agriculture, Umudike, Nigeria, whose scholarly activities are centered on biochemistry, toxicology, environmental health, immunology, and emerging public health technologies. His published research demonstrates interdisciplinary collaboration involving biochemical mechanisms, environmental risk assessment, immunomodulation, and artificial intelligence applications in healthcare. Based on the available scholarly record, his work reflects an emphasis on translating laboratory findings into practical biomedical and public health applications.[1][2]

Abstract

Promise Paul has contributed to a growing body of interdisciplinary research spanning biochemical sciences, environmental toxicology, occupational exposure assessment, immunology, and public health. His publications investigate volatile organic compound interactions with biological receptors, bioaccumulation of toxic elements in aquatic organisms, antioxidant mechanisms, immune regulation, and artificial intelligence applications in disease surveillance. Collectively, these studies contribute to understanding disease prevention, environmental safety, and biomedical innovation while supporting evidence-based public health practices.[2][3]

Keywords

Biochemistry, Environmental Toxicology, Occupational Health, Drug Design, Artificial Intelligence, Public Health, Immunology, Oxidative Stress

Introduction

Modern biomedical research increasingly depends on interdisciplinary collaboration to address complex health and environmental challenges. Promise Paul’s research portfolio reflects this approach by integrating biochemical investigation with environmental science, clinical perspectives, and computational technologies. His collaborative publications examine toxicological mechanisms, disease prevention, environmental monitoring, and innovative analytical strategies that support scientific understanding across multiple disciplines.[2]

Research Profile

The available publication record indicates research interests spanning molecular toxicology, pharmacology, environmental biochemistry, immunomodulation, veterinary science, and digital public health. His collaborative studies frequently investigate biological responses to toxic compounds, mechanisms of oxidative stress, environmental contaminants, and innovative approaches for disease surveillance using artificial intelligence technologies. These areas collectively contribute to improving scientific understanding of health risks and preventive strategies.[1]

Research Contributions

  • Investigated volatile organic compound interactions with drug receptors to support rational drug discovery strategies.
  • Contributed to environmental health studies evaluating toxic element bioaccumulation in commercially important fish species.
  • Participated in immunology research examining therapeutic approaches for congenital immunodeficiencies.
  • Co-authored research exploring ethical implementation of artificial intelligence for public health surveillance.
  • Investigated antioxidant effects of L-Arginine against carbon tetrachloride-induced oxidative damage in experimental animal models.

Publications

  1. Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure. Processes, 13(1), 154. DOI: https://doi.org/10.3390/pr13010154
  2. Bioaccumulation and Human Health Risk Assessment of Potentially Toxic Elements in Commercial Fish Species. International Journal of Environmental Research and Public Health, 23(7), 827.
  3. Immunomodulation in Congenital Immunodeficiencies: Targeting Innate and Adaptive Pathways. Clinical Medicine and Integrative Therapies, 1(1), 36–52.
  4. Artificial Intelligence for Public Health Surveillance: Promises, Pitfalls, and an Ethics-Equity Roadmap for Deployment. Disease Prevention and Epidemiology, 1(1), 22–39.
  5. Antioxidant Effects of L-Arginine on Redox Profile of Carbon Tetrachloride (CCl4)-Intoxicated Albino Rats. Journal of Sustainable Veterinary & Allied Sciences, 7(4), 385–391.

Research Impact

Although currently representing an early-stage publication profile, the available scholarly metrics indicate growing visibility through peer-reviewed publications and citations. The interdisciplinary nature of these investigations contributes to knowledge spanning environmental safety, biomedical science, toxicology, and digital health while encouraging collaboration across multiple scientific disciplines.[2]

Award Suitability

Promise Paul’s research portfolio demonstrates characteristics commonly considered for emerging research recognition, including interdisciplinary collaboration, publication in peer-reviewed journals, investigation of contemporary biomedical and environmental issues, and contributions to public health research. The Innovative Research Award appropriately recognizes researchers developing multidisciplinary scientific approaches with potential societal relevance.[1][2]

Conclusion

Promise Paul has established an emerging interdisciplinary research profile focused on biochemistry, environmental health, immunology, toxicology, and artificial intelligence applications in medicine. His collaborative publications demonstrate scientific engagement with important biomedical and environmental challenges, supporting continued academic development and making his work consistent with the objectives of recognizing innovative scientific research.

References

  1. Google Scholar. (n.d.). Promise Paul – Google Scholar Citations Profile.
    https://scholar.google.com/citations?user=o4j7GMIAAAAJ&hl=en&oi=ao
  2. Processes. (2025). Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure.DOI:https://doi.org/10.3390/pr13010154
  3. ORCID. (n.d.). Promise Paul ORCID Record.
    https://orcid.org/0009-0002-7532-8409
  4. Crossref DOI Foundation. (n.d.). DOI Metadata and Scholarly Record Services.

Asli Altunbas | Medicine and Dentistry | Young Researcher Award

Published on by Academic Achievements

Young Researcher Award

Asli Altunbas
Bahcesehir University School of Medicine, Türkiye

Asli Altunbas
Affiliation Bahcesehir University School of Medicine
Country Türkiye
Scopus ID 59476326700
Documents 3
Citations 1
h-index 1
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Asli Altunbas is a medical researcher and final-year medical student at Bahçeşehir University School of Medicine in Istanbul, Türkiye. Her academic portfolio demonstrates active engagement in clinical medicine, pathology, oncology, pediatrics, cardiovascular sciences, and translational healthcare research. Through scholarly publications, international observership experiences, and student-led educational initiatives, she has contributed to the development of evidence-based medical knowledge and interdisciplinary clinical learning.[1]

Abstract

This academic profile summarizes the educational background, research activities, scientific publications, leadership roles, and community engagement of Sabire Aslı ALTUNBAŞ. Her work spans pediatric health, oncology, pathology, cardiovascular medicine, and medical education. Through active participation in clinical research and international academic collaborations, she has demonstrated a commitment to advancing healthcare knowledge and promoting evidence-based medicine among future healthcare professionals.[2]

Keywords

Medical Research, Oncology, Pathology, Pediatrics, Cardiology, Clinical Education, Artificial Intelligence in Medicine, Translational Research, Medical Students, Healthcare Innovation.

Introduction

Medical students increasingly contribute to scientific discovery through research participation and interdisciplinary collaboration. Sabire Aslı ALTUNBAŞ represents this emerging generation of clinician-scientists through her involvement in peer-reviewed publications, medical education projects, and clinical observation programs. Her academic journey reflects a strong integration of clinical learning, scientific inquiry, and professional development.[1]

Research Profile

Her research interests encompass oncology, neuropathology, pediatric health, inflammatory biomarkers, cardiovascular medicine, and artificial intelligence applications in healthcare. She has participated in retrospective clinical studies, pathology investigations, and comparative analyses involving AI-assisted clinical interpretation. These activities demonstrate an interdisciplinary approach to addressing contemporary healthcare challenges.[3]

Research Contributions

  • Co-authored studies investigating pediatric inflammatory biomarkers and body mass index associations.
  • Contributed to pathology research on primary central nervous system lymphomas.
  • Participated in studies exploring recurrence predictors in granulosa cell tumors.
  • Engaged in research comparing human expertise and artificial intelligence in neonatal intensive care decision support.
  • Supported policy-oriented healthcare initiatives concerning refugee health systems.

Publications

  • Association Between Body Mass Index Categories and Hemogram-Derived Ratios and Inflammatory Indices in Children Aged 6–9 Years. DOI: 10.12659/MSM.952004
  • Primary Central Nervous System Lymphomas and Immune-Privileged Site Lymphomas. DOI: 10.4103/ijpm.ijpm_401_24
  • Predicting Recurrence in Adult Granulosa Cell Tumors: The Role of KI67, p53 and TERT Mutations.
  • Time is Brain: Early Diagnosis of Post-Transplant Lymphoproliferative Disorder Presenting as Primary CNS Diffuse Large B-Cell Lymphoma (Under Review).

Research Impact

Beyond publications, Altunbaş has expanded her academic experience through observerships at Mayo Clinic in heart failure, transplantation medicine, and radiology. She has also established peer-learning initiatives that support practical clinical skills training among pre-clinical medical students. These contributions highlight her commitment to research dissemination, mentorship, and healthcare education.[4]

Award Suitability

Based on her academic achievements, publication record, leadership initiatives, and international clinical exposure, Sabire Aslı ALTUNBAŞ demonstrates characteristics associated with emerging excellence in medical research. Her multidisciplinary engagement and commitment to scientific inquiry make her a suitable candidate for recognition within early-career and student researcher award categories.[2]

Conclusion

Sabire Aslı ALTUNBAŞ has developed a promising academic profile characterized by research productivity, clinical engagement, educational leadership, and community service. Her ongoing contributions to medicine and healthcare research illustrate a strong foundation for future scientific and clinical accomplishments.

References

  1. Bahçeşehir University School of Medicine. Academic and professional profile of Sabire Aslı ALTUNBAŞ.
  2. Altunbaş, S.A. Research activities, leadership initiatives, and academic achievements compiled from curriculum vitae records.
  3. Association Between Body Mass Index Categories and Hemogram-Derived Ratios and Inflammatory Indices in Children Aged 6–9 Years.https://doi.org/10.12659/MSM.952004
  4. Indian Journal of Pathology and Microbiology. Primary Central Nervous System Lymphomas.https://doi.org/10.4103/ijpm.ijpm_401_24

Xinge Du | Architectural Design and Theory | Research Excellence Award

Published on by Academic Achievements

Dr. Xinge Du | Architectural Design and Theory | Research Excellence Award

Tianjin University | China

Dr. Xinge Du (Dylan) is a Ph.D. candidate in Architecture at Tianjin University, specializing in green building, low-carbon campus planning, and building performance optimization. His research integrates sustainable design principles with advanced simulation and BIM technologies to develop practical solutions for energy-efficient built environments. He previously earned his Master’s and Bachelor’s degrees from Taiyuan University of Technology, where he received multiple academic scholarships and honors. Du has published in high-impact journals such as Scientific Reports and Sustainability, contributing innovative frameworks for low-carbon building retrofits and campus design. Actively involved in industry-linked projects, he has led architectural designs incorporating photovoltaic systems and passive energy strategies. His award-winning work in rural housing and campus retrofitting demonstrates a strong commitment to sustainable development and real-world architectural innovation.

Citation Metrics (Scopus)

9

6

3

0

Citations
6

Documents
2

h-index
2

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Published on by Academic Achievements

Prof. Dr. Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Università degli Studi di Bari – Dipartimento di Medicina Veterinaria | Italy

Prof. Annamaria Pratelli is a Full Professor of Infectious Diseases of Animals at the University of Bari, Italy, and a globally recognized expert in veterinary virology and coronavirus research. She has been listed among the World’s Top 2% Scientists by Stanford University (2022 and 2025) and has contributed significantly to the study of animal coronaviruses and zoonotic diseases. With over 205 peer-reviewed publications, an H-index of 33, and more than 3,100 citations (Scopus, 2026), her work spans viral pathogenesis, epidemiology, and antiviral strategies. She has led multiple nationally funded research projects and actively contributed to SARS-related task forces in collaboration with national health authorities. Prof. Pratelli serves on several international editorial boards and has extensive experience in scientific evaluation and governance, with impactful contributions to One Health and global infectious disease research.

Citation Metrics (Scopus)

3500

2500

1500

500

0

Citations
3,125

Documents
123

h-index
34

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

Evidence for evolution of canine parvovirus type 2 in Italy
– Journal of General Virology (2001) | Citations: 854

A canine parvovirus mutant is spreading in Italy
– Journal of Clinical Microbiology (2004) | Citations: 180

Genetic diversity of a canine coronavirus detected in pups with diarrhoea in Italy
– Journal of Virological Methods (2003) | Citations: 155

Development of a nested PCR assay for the detection of canine coronavirus
– Journal of Virological Methods (1999) | Citations: 135

 

Mohammad Kamil | Pharmaceutical Science | Distinguished Scientist Award

Published on by Academic Achievements

Professor Dr. Mohammad Kamil | Pharmaceutical Science | Distinguished Scientist Award

Lotus Holistic Health Institute | United Arab Emirates

Prof. Dr. Mohammad Kamil, M.Sc., M.Phil., Ph.D., D.Sc., C.Chem., F.R.S.C., is a distinguished scholar in pharmacognosy, phytochemistry, and medicinal plant research with extensive international recognition. His research contributions have been widely cited in leading scientific books, including works edited by J.B. Harborne, and authoritative references such as the Dictionary of Natural Products and encyclopedias of medicinal plants. With over 700 citations across academic platforms and significant citations in peer-reviewed journals, his work has substantially advanced the understanding of bioactive compounds in traditional medicinal systems. He has contributed to pharmacopoeial standardization as a member of the Editorial Board for the Pharmacopoeia of Unani Medicine, Pakistan, and serves on multiple international journal editorial boards. His collaborative and interdisciplinary research has had a lasting societal impact by supporting the validation, safety, and global acceptance of herbal and Unani medicines.

Citation Metrics (Scopus)

600

400

200

0

Citations
563

Documents
19

h-index
8

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Aishwarya R Kurdekar | Pharmaceutical Science | Best Researcher Award

Published on by Academic Achievements

Ms. Aishwarya R Kurdekar |  Pharmaceutical Science | Best Researcher Award

Bapuji pharmacy college | India
Ms. Aishwarya R. Kurdekar is a dedicated Pharmacology Research Scholar at Bapuji Pharmacy College, specializing in anticancer pharmacology, natural product drug discovery, and oxidative stress mechanisms. She holds an M.Pharm in Pharmacology and has contributed to advancing plant-based therapeutic research through both experimental and computational approaches. Her notable publication in Cell and Tissue Biology (Springer Nature) explores the antioxidant and anticancer potential of Argemone mexicana seed extract using HepG2 liver cancer cell lines. Her research integrates in-vitro studies with LC-MS profiling, network pharmacology, and molecular docking to identify bioactive compounds and molecular targets. She has actively collaborated with academic researchers and presented her work at national conferences, earning recognition including a Best E-Poster Award. Her ongoing research focuses on pancreatic cancer (PANC-1) cell lines, aiming to develop safer, effective anticancer strategies with societal impact.

Featured Publications

 

Pouyan Ebrahimi | Medicine and Dentistry | Research Excellence Award

Published on by Academic Achievements

Dr. Pouyan Ebrahimi | Medicine and Dentistry | Research Excellence Award

Babol university of medical sciences | Iran

Dr. Pouyan Ebrahimi is a medical researcher and physician with over six years of experience in clinical and non-clinical research. He earned his M.D. from Babol University of Medical Sciences, Iran, and currently serves as the Executive Secretary of Health System Research in Babol. His research focuses on cancer epidemiology, public health, systematic reviews, and meta-analysis, with particular emphasis on disease outcomes and healthcare effectiveness. Dr. Ebrahimi has authored more than 30 peer-reviewed publications and has achieved a Scopus h-index of 5 with 97 citations, reflecting his growing academic impact. He actively collaborates with international researchers and contributes as a reviewer for several high-impact journals. His work supports evidence-based medical practice and contributes to improving public health outcomes globally.

Citation Metrics (Scopus)

160

120

80

40

0

Citations
97

Documents
34

h-index
5

🟦 Citations 🟥 Documents 🟩 h-index

Scopus

Google Scholar

ORCID Profile

Featured Publications

miRNAs and multiple myeloma: focus on the pathogenesis, prognosis, and drug resistance
– Technology in Cancer Research & Treatment (2023) | Citations: 9

Huai-Jen Tsai | Transgenesis | Excellence in Research Award

Published on by Academic Achievements

Prof. Dr. Huai-Jen Tsai | Transgenesis | Excellence in Research Award 

Prof. Dr. Huai-Jen Tsai | Transgenesis | Chair Professor at Fu Jen Catholic University | Taiwan

Transgenesis Prof. Dr. Huai-Jen Tsai is a distinguished scientist whose career spans over five decades in molecular biology, marine biotechnology, developmental biology, and particularly gene transgenesis in aquatic organisms. Prof. Dr. Huai-Jen Tsai obtained his B.Sc. in Biology from Fu-Jen Catholic University, followed by an M.Sc. in Marine Biology and Fisheries Science from National Taiwan University, where his master’s thesis analyzed blood and muscle proteins of blenny fish via electrophoresis — grounding him firmly in marine biology and protein biochemistry. He then went on to earn a Ph.D. in Microbiology from Oregon State University, USA, completing a dissertation on “Conjugal transfer of plasmid genes between lactic Streptococcus and Leuconostoc starter cultures,” which provided him with rigorous training in gene transfer, plasmid biology and microbial genetics. This strong educational foundation supported a prolific professional journey: beginning as a research assistant, then serving as a teaching assistant, and eventually becoming a researcher in biotechnology and fermentation in the U.S., before returning to Taiwan to engage in academia and research. Prof. Dr. Huai-Jen Tsai progressed from Associate Professor to Professor — holding significant roles at the Institute of Fisheries Science and the Institute of Molecular and Cellular Biology at National Taiwan University, and later serving as Professor and Director of these institutes. He also held adjunct and visiting professorships, including at the Institute of Biomedical Sciences at Mackay Medical College, and serves as Chair Professor in the Department of Life Science at Fu-Jen Catholic University. Throughout his career, Prof. Dr. Huai-Jen Tsai has combined marine biology, molecular biology, and biotechnology to pioneer the development of transgenic aquatic animals, especially using fish models. His research interests center on gene transgenesis in aquatic materials, developmental biology using model fish, molecular mechanisms of gene regulation, tissue-specific gene expression, environmental biotechnology applications, and the use of transgenic fish as biosensors for environmental toxicants. His lab has developed a wide range of transgenic lines — for example, fluorescent-protein–tagged zebrafish where muscle, heart, eye or ovary tissues are marked, as well as transgenic medaka and other aquaculture species — to study gene regulation, embryonic development, organogenesis, regeneration, and environmental responses. Prof. Dr. Huai-Jen Tsai’s research skills cover a broad array of molecular biology and biotechnology techniques: gene cloning, promoter analysis, microinjection and electroporation gene transfer methods, transgenesis, germ-line transmission, use of fluorescent reporter genes (GFP/RFP) for live imaging, developmental gene expression studies, protein biochemistry, and the use of aquatic model organisms. He has authored many peer-reviewed publications and secured patents for “Novel transgenic zebrafish, gene fragments and methods for producing transgenic zebrafish.” His honors and awards reflect his scientific leadership and teaching excellence, including the MOST Outstanding Research Award, Excellent Teaching Award, recognition as Distinguished Professor, the Y. Z. Hsu Technology Invention Award (Biotechnology Category) for a patent on “Novel Gene Fragment for Use in Golden Zebrafish,” and multiple Outstanding Research Awards, as well as inclusion in the prestigious directories Marquis Who’s Who in various categories — highlighting his global recognition. In conclusion, Prof. Dr. Huai-Jen Tsai stands as a pioneering and visionary scientist whose integration of marine biology, molecular techniques, and transgenic technologies has significantly advanced aquatic biotechnology and developmental biology. His lifelong commitment to gene transgenesis in fish, his development of transgenic aquatic models, and his mentorship of students position him as a foundational figure shaping the future of marine biotechnology, environmental monitoring using transgenic organisms, and developmental biology research.

Profile: ORCID

Featured Publications

Zeng, C.-W., & Tsai, H.-J. (2023). The Promising Role of a Zebrafish Model Employed in Neural Regeneration Following a Spinal Cord Injury. International Journal of Molecular Sciences, 24(18), 13938. 
Tsai, H.-J. (2000). Electroporated Sperm Mediation of a Gene Transfer System for Finfish and Shellfish. Molecular Reproduction and Development, 56, 281–284. 
Tsai, H.-J., Chen, Y.-H., Lin, Y.-J., & Wang, Y.-H. (2006). Spatiotemporal Expression of Zebrafish Keratin 18 During Early Embryogenesis and the Establishment of a Keratin 18:RFP Transgenic Line. Gene Expression Patterns, 6(4), 335–339. 
Hsiao, C.-D., & Tsai, H.-J. (2003). Skin-specific Expression of ictacalcin, a Homolog of the S100 Genes, During Zebrafish Embryogenesis. Developmental Dynamics, 228(4), 745–750.
Chou, C.-Y., Horng, L.-S., & Tsai, H.-J. (2001). Uniform GFP-Expression in Transgenic Medaka (Oryzias latipes) at the F0 Generation. Transgenic Research, 10, 303–315.